Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Vetnostrum Animal Health Co's Revenue for the
three
months ended in Dec. 2025 was NT$373 Mil. Vetnostrum Animal Health Co's average Accounts Receivable for the
three
months ended in Dec. 2025 was NT$220 Mil.
Hence, Vetnostrum Animal Health Co's Receivables Turnover for the
three
months ended in Dec. 2025 was 1.70.
Vetnostrum Animal Health Co (TPE:6936) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Vetnostrum Animal Health Co Receivables Turnover Related Terms
Vetnostrum Animal Health Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vetnostrum Animal Health Co Receivables Turnover Chart
TPE:6936 vs ADM, BG, TSN: Receivables Turnover Comparison
For the Farm Products subindustry, Vetnostrum Animal Health Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vetnostrum Animal Health Co Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Vetnostrum Animal Health Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Vetnostrum Animal Health Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vetnostrum Animal Health Co (TPE:6936) has a Receivables Turnover of 1.70 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vetnostrum Animal Health Co and its competitors. According to the industry distribution chart, Vetnostrum Animal Health Co ranks #1336 out of 1946 companies in the Consumer Packaged Goods industry, placing it in the top 68.7%.
Is Vetnostrum Animal Health Co's Receivables Turnover too high?
Vetnostrum Animal Health Co's current Receivables Turnover is 1.70. The Consumer Packaged Goods industry median Receivables Turnover is 9.33. Vetnostrum Animal Health Co's value of 1.70 is 81.8% below this industry median. Based on the distribution chart, Vetnostrum Animal Health Co ranks #1336 out of 1946 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Vetnostrum Animal Health Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetnostrum Animal Health Co's Receivables Turnover compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Vetnostrum Animal Health Co ranks #1336 out of 1946 companies for Receivables Turnover. This places Vetnostrum Animal Health Co in the lower half of its industry. The industry median Receivables Turnover is 9.33. Vetnostrum Animal Health Co's value of 1.70 is 81.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.33, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vetnostrum Animal Health Co's current Receivables Turnover of 1.70 is 81.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Vetnostrum Animal Health Co and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vetnostrum Animal Health Co's current Receivables Turnover is 1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetnostrum Animal Health Co stock overvalued right now?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co (TPE:6936) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$39.85, compared to a current price of NT$31.75 — trading 20.3% below its estimated fair value. The current Receivables Turnover is 1.70 and 81.8% below the Consumer Packaged Goods industry median of 9.33. Vetnostrum Animal Health Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Vetnostrum Animal Health Co (TPE:6936), the current Receivables Turnover is 1.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vetnostrum Animal Health Co (TPE:6936) Overvalued in 2026?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co stock appears to be undervalued.
The current stock price of NT$31.75 is trading 20.3% below its estimated GF Value™ of NT$39.85.
GuruFocus considers Vetnostrum Animal Health Co to be Modestly Undervalued.
Key valuation signals for TPE:6936:
Receivables Turnover: 1.70
GF Value™: NT$39.85 vs. price of NT$31.75 (20.3% below fair value)
Industry Position: 81.8% below the Consumer Packaged Goods median (#1336 of 1946)
No single metric tells the full story. See the TPE:6936 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vetnostrum Animal Health Co Ltd is mainly engaged in importing, manufacturing, and selling pharmaceuticals and nutrition supplements for animals, feed additives, and feed. It derives a majority of its revenue from the sale of animal pharmaceuticals, medicated feed additives, and feeds and the rendering of drug testing services. Geographically, the company derives maximum revenue from Taiwan, followed by the USA, Malaysia, and other countries.
68GF Score
Get the complete analysis for TPE:6936
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6936 has been successfully added to your 
